Journal List > Tuberc Respir Dis > v.66(4) > 1001357

TOOLS
Moon: Medical Treatment of Sleep Disordered Breathing
Review
Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases 2009; 66(4): 267-273.

Published online: 30 April 2009

DOI: https://doi.org/10.4046/trd.2009.66.4.267

Medical Treatment of Sleep Disordered Breathing

Hwa Sik Moon, M.D.

Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.

Address for correspondence: Hwa Sik Moon, M.D. Department of Internal Medicine, St. Paul's Hospital, The Catholic University of Korea College of Medicine, 620-56, Jeonnong 2-dong, Dongdaemun-gu, Seoul 130-709, Korea. Phone: 82-2-958-2463, Fax: 82-2-968-7250, hsmoon@catholic.ac.kr

Received 13 November 2008       Accepted 11 December 2008

Copyright©2009. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Figures and Tables

Table 1
Diagnostic criteria of sleep apnea syndrome
trd-66-267-i001

*RERAs: respiratory effort related arousals.

Table 2
Risk factors of sleep apnea syndrome
trd-66-267-i002
Table 3
Treatment of obstructive sleep apnea syndrome
trd-66-267-i003

*continuous positive airway pressure, †bilevel positive airway pressure, ‡autotitrating positive airway pressure, §uvuloplalatopharyngoplasty, ∥laser-assisted uvuloplasty.

References

1. Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 2007. 1st ed. Westchester: American Academy of Sleep Medicine.
2. American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic & coding manual. 2005. 2nd ed. Westchester: American Academy of Sleep Medicine.
3. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005. 365:1046–1053.
4. Moon HS. The Korean Academy of Tuberculosis and Respiratory Disease. Sleep apnea. Respiratory Disease. 2004. 1st ed. Seoul: Koon Ja Publishing, Inc.;993–1007.
5. Moon HS. The Korean Association of Internal Medicine. Sleep apnea syndrome. Prescription guide for the primary care physician (medical part). 2004. 2nd ed. Seoul: Korean Institute of Medicine;779–785.
6. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for obstructive sleep apnea task force of the standards of practice committee of the American Academy of Sleep Medicine. Sleep. 2006. 29:1036–1044.
7. Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med. 1996. 154:279–289.
8. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000. 284:3015–3021.
9. George CF, Millar TW, Kryger MH. Sleep apnea and body position during sleep. Sleep. 1988. 11:90–99.
10. Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF. Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. Chest. 1999. 115:771–781.
11. Skinner MA, Kingshott RN, Filsell S, Taylor DR. Efficacy of the 'tennis ball technique' versus nCPAP in the management of position-dependent obstructive sleep apnoea syndrome. Respirology. 2008. 13:708–715.
12. Taasan VC, Block AJ, Boysen PG, Wynne JW. Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med. 1981. 71:240–245.
13. Höijer U, Hedner J, Ejnell H, Grunstein R, Odelberg E, Elam M. Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study. Eur Respir J. 1994. 7:2011–2015.
14. Lofaso F, Goldenberg F, Thebault C, Janus C, Harf A. Effect of zopiclone on sleep, night-time ventilation, and daytime vigilance in upper airway resistance syndrome. Eur Respir J. 1997. 10:2573–2577.
15. Robinson RW, Zwillich CW, Bixler EO, Cadieux RJ, Kales A, White DP. Effects of oral narcotics on sleep-disordered breathing in healthy adults. Chest. 1987. 91:197–203.
16. Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab. 2003. 88:3605–3613.
17. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981. 1:862–865.
18. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003. 348:1233–1241.
19. Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006. 29:375–380.
20. Pépin JL, Leger P, Veale D, Langevin B, Robert D, Lévy P. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest. 1995. 107:375–381.
21. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest. 1999. 116:403–408.
22. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999. 159:1108–1114.
23. Hirshkowitz M, Sharafkhaneh A. Positive airway pressure therapy of OSA. Semin Respir Crit Care Med. 2005. 26:68–79.
24. Ballard RD, Gay PC, Strollo PJ. Interventions to improve compliance in sleep apnea patients previously non-compliant with continuous positive airway pressure. J Clin Sleep Med. 2007. 3:706–712.
25. Ayas NT, Patel SR, Malhotra A, Schulzer M, Malhotra M, Jung D, et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep. 2004. 27:249–253.
26. Berry RB, Parish JM, Hartse KM. The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. An American Academy of Sleep Medicine review. Sleep. 2002. 25:148–173.
27. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993. 147:887–895.
28. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest. 2002. 121:430–435.
29. Marshall NS, Barnes M, Travier N, Campbell AJ, Pierce RJ, McEvoy RD, et al. Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis. Thorax. 2006. 61:430–434.
30. Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, Lima-Alvarez J, Benitez MA, Almeida-Gonzalez C. Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest. 2007. 132:1847–1852.
31. Chan AS, Lee RW, Cistulli PA. Dental appliance treatment for obstructive sleep apnea. Chest. 2007. 132:693–699.
32. Kushida CA, Morgenthaler TI, Littner MR, Alessi CA, Bailey D, Coleman J Jr, et al. Practice parameters for the treatment of snoring and Obstructive Sleep Apnea with oral appliances: an update for 2005. Sleep. 2006. 29:240–243.
33. Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med. 2002. 166:743–748.
34. Brownell LG, West P, Sweatman P, Acres JC, Kryger MH. Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med. 1982. 307:1037–1042.
35. Hannhart B, Pickett CK, Moore LG. Effects of estrogen and progesterone on carotid body neural output responsiveness to hypoxia. J Appl Physiol. 1990. 68:1909–1916.
36. Schwartz JR, Hirshkowitz M, Erman MK, Schmidt-Nowara W. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest. 2003. 124:2192–2199.
37. Oliven A, Tov N, Geitini L, Steinfeld U, Oliven R, Schwartz AR, et al. Effect of genioglossus contraction on pharyngeal lumen and airflow in sleep apnoea patients. Eur Respir J. 2007. 30:748–758.
38. Staniforth AD, Kinnear WJ, Starling R, Hetmanski DJ, Cowley AJ. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J. 1998. 19:922–928.
39. Okin PM, Devereux RB, Howard BV, Fabsitz RR, Lee ET, Welty TK. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation. 2000. 101:61–66.
40. Thomas RJ, Daly RW, Weiss JW. Low-concentration carbon dioxide is an effective adjunct to positive airway pressure in the treatment of refractory mixed central and obstructive sleep-disordered breathing. Sleep. 2005. 28:69–77.
TOOLS
Similar articles